Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.

We have previously isolated the protein MIA, which is secreted from melanoma cells, and identified highly restricted expression patterns in melanocytic tumors. Preliminary studies of the human MIA gene provided evidence that the promoter is specifically activated in melanoma cells but is silent in nonmelanocytic cells and benign melanocytes. In this study we aimed to identify cis-regulatory promoter elements that mediate promoter activation during malignant transformation of melanocytes. We therefore subcloned 1.4 kb of the murine MIA promoter and a series of 5' deletion constructs into a luciferase reporter plasmid and identified the most active cis-regulatory element between nucleic acids -230 and -130. Cloning oligomeric fragments of this promoter region in front of a minimal TK promoter revealed a 30 bp enhancer element mediating expression of the reporter gene in melanoma cells but not in melanocytes or nonmelanocytic cells. Gel mobility shift assays and southwestern blots led to the identification of specific DNA-protein complexes in melanoma cells. Fine mutational analysis of the cis-regulatory promoter element showed that two critical nucleic acid residues are essential for both transcriptional activity and formation of the band shift complexes. By an initial small-scale affinity purification we were able to isolate a protein approximately 32 kDa in size from melanoma cells, which we refer to as MATF ("melanoma-associated transcription factor"). Our study identified for the first time MATF, a transcription factor that is upregulated or activated during malignant transformation of melanocytes.

[1]  S Sakano,et al.  Trans‐activation of the Mouse Cartilage‐Derived Retinoic Acid‐Sensitive Protein Gene by Sox9 , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  V. Setaluri,et al.  Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1. , 1999, Biochemical and biophysical research communications.

[3]  A. Bosserhoff,et al.  In situ expression patterns of melanoma‐inhibiting activity (MIA) in melanomas and breast cancers , 1999, The Journal of pathology.

[4]  C. R. Goding,et al.  Brachyury-Related Transcription Factor Tbx2 and Repression of the Melanocyte-Specific TRP-1 Promoter , 1998, Molecular and Cellular Biology.

[5]  D. Fisher,et al.  Involvement of Microphthalmia in the Inhibition of Melanocyte Lineage Differentiation and of Melanogenesis by Agouti Signal Protein* , 1998, The Journal of Biological Chemistry.

[6]  A. Bosserhoff,et al.  In vitro modulation of human melanoma cell invasion and proliferation by all-frans-retinoic acid , 1998, Melanoma research.

[7]  L. Sandell,et al.  Regulation of the Mouse Cartilage-derived Retinoic Acid-sensitive Protein Gene by the Transcription Factor AP-2* , 1998, The Journal of Biological Chemistry.

[8]  W. Stolz,et al.  Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. , 1997, Cancer research.

[9]  A. Bosserhoff,et al.  Mouse CD‐RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  A. Bosserhoff,et al.  Structure and Promoter Analysis of the Gene Encoding the Human Melanoma-inhibiting Protein MIA (*) , 1996, The Journal of Biological Chemistry.

[11]  A. Bosserhoff,et al.  Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones , 1995, International journal of cancer.

[12]  S. Shibahara,et al.  Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene , 1994, Molecular and cellular biology.

[13]  G. Schütz,et al.  The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements. , 1994, The Journal of biological chemistry.

[14]  A. Bosserhoff,et al.  Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. , 1994, Cancer research.

[15]  H. Suzuki,et al.  Cloning of the human DOPAchrome tautomerase/tyrosinase-related protein 2 gene and identification of two regulatory regions required for its pigment cell-specific expression. , 1994, The Journal of biological chemistry.

[16]  A. Monaghan,et al.  A cell‐specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number‐related expression in transgenic mice. , 1994, The EMBO journal.

[17]  U. Yavuzer,et al.  Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, MSF , 1994, Molecular and cellular biology.

[18]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[19]  S. Shibahara,et al.  Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene. , 1992, The Journal of biological chemistry.

[20]  U. Yavuzer,et al.  Positive and negative elements regulate a melanocyte-specific promoter , 1992, Molecular and cellular biology.

[21]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[22]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[23]  G. Martin,et al.  Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.